SciSparc 2022 Corporate Presentation NASDAQ SPRC

SciSparc develops proprietary cannabinoid-based pharmaceutical treatments designed to increase patient safety by reducing required doses while maintaining therapeutic effectiveness. The company leverages platform technologies to advance its product pipeline through clinical trials and research initiatives.